Anke Nijhuis
Imperial College London
H-index: 13
Europe-United Kingdom
Top articles of Anke Nijhuis
Abstract B096: Targeting RNA splicing factor RBM39 improves therapy responses in ovarian high-grade serous carcinoma
Cancer Research
2024/3/4
Epigenetic and metabolic reprogramming of fibroblasts in Crohn's disease strictures reveals histone deacetylases as therapeutic targets
J Crohns Colitis
2023/12/9
Anke Nijhuis
H-Index: 10
Alessandro Armuzzi
H-Index: 39
RBM39: A druggable metabolic sensor linking RNA splicing, transcriptional regulation, and metabolic reprogramming in cancer
Molecular Cell
2023/12/7
Anke Nijhuis
H-Index: 10
Pharmacological depletion of RNA splicing factor RBM39 by indisulam synergizes with PARP inhibitors in high-grade serous ovarian carcinoma
Cell Reports
2023/10/31
Iain Mcneish
H-Index: 45
Anke Nijhuis
H-Index: 10
Small-molecule Wnt inhibitors are a potential novel therapy for intestinal fibrosis in Crohns disease
Clinical Science
2022/10
Anke Nijhuis
H-Index: 10
Indisulam targets RNA splicing and metabolism to serve as a novel therapeutic strategy for high-risk neuroblastoma
Nature Communications
2022/3/16
RNA‐binding motif protein 39 (RBM39): An emerging cancer target
2022/6
Anke Nijhuis
H-Index: 10
Lactic acidosis induces resistance to the pan-Akt inhibitor uprosertib in colon cancer cells
British Journal of Cancer
2020/4/28
Anke Nijhuis
H-Index: 10
Co-Authors
